[分析了8例原发性中体大B细胞淋巴瘤]
1Medical Oncology Department, Pediatric Oncology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Clinical Discipline of Pediatric Oncology, Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing 100045, China.
Zhonghua er ke za zhi = Chinese journal of pediatrics
|July 22, 2025
概括
在儿童中,主要的中间体大B细胞淋巴瘤 (PMBCL) 通常呈现为大型中间体瘤. 在这项研究中,DA-EPOCH+R化疗方案显示出高疗效,所有儿科患者都幸存下来.
科学领域:
- 儿科瘤学 儿科瘤学
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学


